logo
Select company
Select metric
$ -2.66MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
39
Sector
44
Industry
47
History
45
$ 2.82Close
$ 1.41 - $ 4 52-Week Range
Ticker Information

Ticker

FBIO

Company Name

FORTRESS BIOTECH INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

FORTRESS BIOTECH INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

FBIO - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -2.66M
3/31/2025$ 6.72M
12/31/2024$ -24.55M
9/30/2024$ -13.83M
6/30/2024$ -10.95M
3/31/2024$ -69.08M
12/31/2023$ -97.59M
9/30/2023$ -135.83M
6/30/2023$ -161.78M
3/31/2023$ -134.81M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • FORTRESS BIOTECH INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 69.02M.
  • Over the past 5 years, FORTRESS BIOTECH INC's average CF - Chg. Cash has been $ -18.45M.
  • The median CF - Chg. Cash for FORTRESS BIOTECH INC during this period was $ -12.39M
  • FORTRESS BIOTECH INC reached its highest CF - Chg. Cash over the past 5 years at $ 139.03M.
  • The lowest CF - Chg. Cash recorded by FORTRESS BIOTECH INC in the same timeframe $ -161.78M

FORTRESS BIOTECH INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
DOMH : DOMINARI HOLDINGS INC $ 3.67MICCC : IMMUCELL CORP $ 4.67MMGX : METAGENOMI INC $ -34.33MEQ : EQUILLIUM INC $ 438KADAP : ADAPTIMMUNE THERAPEUTICS PLC $ -186.9MBRNS : BARINTHUS BIOTHERAPEUTICS PLC $ -29.99MMRSN : MERSANA THERAPEUTICS INC $ 17.97MVRCA : VERRICA PHARMACEUTICALS INC $ -16.53MIVVD : INVIVYD INC $ -112.98MIRD : OPUS GENETICS INC $ -8.98M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

FBIO - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -161.78M

Minimum

Jun 30, 2023

$ 139.03M

Maximum

Mar 31, 2021

$ -18.45M

Average

$ -12.39M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.17M with a standard deviation of $ 44.93M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.17M
median$ 115.89K
std$ 44.93M